GLP-1 agonists may hasten progression of diabetic retinopathy Dr. Kamal Kant Kohli7 Aug 2023 11:30 AM ISTUSA: Studies have linked the use of GLP-1 receptor agonists with exacerbation of macular disease that frequently occurs in diabetes...
Tirzepatide outscores Semglutide for weight loss in head to head comparison Dr Kartikeya Kohli11 July 2023 10:00 AM ISTObesity treatment widely ranges from lifestyle changes to many drugs. Obesity is now recognized as a disease and treatments that induce short-term...
Tirzepatide has unique activity to stimulate insulin secretion Dr. Kamal Kant Kohli7 Jun 2023 10:30 AM ISTTirzepatide, a drug approved for diabetes and on the fast track for approval as a weight loss therapy, works through a unique ability to activate two...
Eli Lilly Gets CDSCO Panel Nod to Import, Market antidiabetic drug Tirzepatide Dr. Divya Colin16 May 2023 6:00 PM ISTNew Delhi: Pharmaceutical major, Eli Lilly has got the green signal from the Subject Expert Committee (SEC) functional under Central Drug Standard...
Eli Lilly raises annual profit forecast on strength of diabetes drug Ruchika Sharma30 April 2023 2:30 PM ISTBengaluru: Eli Lilly and Co on Thursday raised its annual revenue and profit forecasts after topping first-quarter sales estimates on demand for its...
Tirzepatide leads to 15.7 percent weight loss in overweight/obese adults with type 2 diabetes in SURMOUNT-2 Dr. Kamal Kant Kohli29 April 2023 11:30 AM ISTUSA: Findings from SURMOUNT-2 trial showed that overweight/obese adults with type 2 diabetes taking 15 mg of the once-weekly tirzepatide (Mounjaro)...
Tirzepatide use linked to GI adverse events in dose dependant manner Medha Baranwal26 April 2023 11:00 AM ISTUSA: A systematic review published in the Journal of the Endocrine Society details the incidence rate of each adverse event at three tirzepatide doses...
Eli Lilly diabetes drug Mounjaro back to shelf after two month shortage Ruchika Sharma22 Feb 2023 1:30 PM ISTAmerica: Eli Lilly & Co said on Tuesday all doses of its new diabetes drug Mounjaro were now available with wholesalers having inventory on...
USFDA adds Eli Lilly diabetes drug Mounjaro to list of drugs facing shortages Ruchika Sharma18 Dec 2022 2:00 PM ISTThe company is expanding its manufacturing capacity for the two drugs through its facility in North Carolina, and doubling it by the end of 2023.
Eli Lilly hopes to launch as many as 5 new treatments next year Ruchika Sharma14 Dec 2022 3:15 PM ISTIndianapolis: Eli Lilly and Co said on Tuesday it hopes to launch as many as five new treatments next year that could drive growth through the decade...
FDA Fast Tracks tirzepatide for treatment of obesity and weight-related comorbidities Dr. Kamal Kant Kohli8 Oct 2022 10:00 AM ISTThe U.S. Food and Drug Administration (FDA) has Fast Tracked tirzepatide for the treatment of weight-related comorbidities, patients with obesity, or...
Eli Lilly gets USFDA Fast Track designation for Tirzepatide to treat adults with obesity Ruchika Sharma7 Oct 2022 12:15 PM ISTTirzepatide is a once-weekly GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist.
